Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: October 4, 2022

Actavis Totowa Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for ACTAVIS TOTOWA, and what generic and branded alternatives to ACTAVIS TOTOWA drugs are available?

ACTAVIS TOTOWA has twenty-two approved drugs.

Summary for Actavis Totowa

US Patents:	0
Tradenames:	17
Ingredients:	17
NDAs:	22

Drugs and US Patents for Actavis Totowa

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign up for a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Actavis Totowa	FLUDARABINE PHOSPHATE	fludarabine phosphate	INJECTABLE;INJECTION	078610-001	Feb 11, 2009	AP	RX	No	Yes		See Plans and Pricing				See Plans and Pricing
Actavis Totowa	GEMCITABINE HYDROCHLORIDE	gemcitabine hydrochloride	INJECTABLE;INJECTION	079160-001	Jul 25, 2011		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Actavis Totowa	TOPIRAMATE	topiramate	TABLET;ORAL	078637-004	Feb 27, 2013		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Actavis Totowa	EPIRUBICIN HYDROCHLORIDE	epirubicin hydrochloride	INJECTABLE;INJECTION	065445-001	Sep 18, 2008		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Actavis Totowa	REPAGLINIDE	repaglinide	TABLET;ORAL	090008-003	Jan 22, 2014		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Actavis Totowa	LAMOTRIGINE	lamotrigine	TABLET;ORAL	078669-004	Apr 8, 2011		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca

Harvard Business School

Boehringer Ingelheim

McKesson

Johnson and Johnson

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.